The origin of the bone scan as a tumour marker in prostate cancer.
AuthorsClarke, Noel W
AffiliationHope and Christie Hospitals, Manchester, UK
MetadataShow full item record
CitationThe origin of the bone scan as a tumour marker in prostate cancer. 2006, 50 (5):873-8 Eur. Urol.
- Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphatase.
- Authors: Barichello M, Gion M, Bonazza A, Delli Ponti US, Bolgan A, Contemori GP, Barioli P, Capitanio G, Pecori B, Omacini S
- Issue date: 1995
- Re: Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
- Authors: Andriole GL, Catalona WJ, Becich M
- Issue date: 1992 Feb
- Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancer.
- Authors: Hetherington JW, Siddall JK, Cooper EH
- Issue date: 1988
- [Relation between serum PAP (prostate acid phosphatase) and bone scintigraphy in prostatic cancer].
- Authors: Aizawa T, Itoh T, Tsujino S, Namiki K, Miki M
- Issue date: 1992 Nov
- The bone scan as a tumour marker in prostatic carcinoma.
- Authors: Chisholm GD, Stone AR, Beynon LL, Merrick MV
- Issue date: 1982